Hong Kong Real Estate Stock News

Nanshan Aluminium International Holdings (SEHK:2610) has put up a solid set of FY 2025 numbers, with first half revenue of US$596.8 million and basic EPS of US$0.46 framing the latest performance. The company has seen first half revenue move from US$423.3 million and EPS of US$0.30 in FY 2024 to US$596.8 million and US$0.46 in FY 2025. This progression sets up a margin story that investors may track closely as profit levels and pricing power come under closer scrutiny. See our full analysis...

Voicecomm Technology (SEHK:2495) has reported its FY 2025 results with first half revenue of C¥478.67 million, basic EPS of C¥2.10 and net income excluding extra items of C¥74.72 million, while the trailing twelve months show revenue of C¥1.01 billion and EPS of C¥3.81 backed by C¥135.48 million of net income. Over recent periods the company has seen revenue range from C¥371.17 million to C¥570.24 million per half year. EPS has moved from a loss of C¥19.09 in 2024 H1 to positive C¥2.99 in...

Lianlian DigiTech (SEHK:2598) has just posted FY 2025 first half results with revenue of C¥782.7 million and basic EPS of C¥1.42, putting fresh numbers behind its recent move into profitability and a share price of C¥5.98. Over the last three reported half years, revenue has moved from C¥617.4 million in 1H 2024 to C¥697.6 million in 2H 2024 and now C¥782.7 million. Over the same periods, basic EPS shifted from a loss of C¥0.34 in 1H 2024 to C¥0.17 in 2H 2024 and C¥1.42 in 1H 2025. This sets...

Cloud Factory Technology Holdings (SEHK:2512) has reported its FY 2025 results with first half revenue of C¥406.8 million and basic EPS of C¥0.0319, setting the tone against a trailing twelve month picture that shows revenue of C¥943.5 million and EPS of C¥0.02. Over the last few reporting periods, revenue has moved from C¥369.7 million in 1H FY 2024 to C¥337.9 million in 2H FY 2024 and then to C¥406.8 million in 1H FY 2025, while basic EPS shifted from C¥0.0322 to a small loss of C¥0.0005...

Latest FY 2025 Results Set Up The Earnings Story Innovent Biologics (SEHK:1801) has just reported its FY 2025 numbers with second half revenue of about C¥7.1b and basic EPS of C¥0.01 loss per share, while on a trailing twelve month basis revenue sits at roughly C¥13.0b and basic EPS at C¥0.48. Over recent reporting halves the company has seen revenue move from C¥5.5b in 2H 2024 to C¥6.0b in 1H 2025 and then to C¥7.1b in 2H 2025, alongside basic EPS shifting from C¥0.18 in 2H 2024 to C¥0.51 in...

Yeahka (SEHK:9923) just released its FY 2025 first half numbers, with revenue of C¥1.6b, basic EPS of C¥0.11, and trailing 12 month EPS of C¥0.23 supported by net income of C¥92.2m. The company has seen revenue move from C¥1.58b in 1H 2024 to C¥1.51b in 2H 2024 and then to C¥1.64b in 1H 2025. Net income excluding extra items tracked from C¥31.6m to C¥50.8m to C¥43.1m over the same periods, setting up a results season where investors are watching how improving profit margins interact with the...

REPT BATTERO Energy (SEHK:666) has just posted its FY 2025 first half numbers, with revenue of C¥9.5b and a basic EPS loss of C¥0.03, alongside trailing twelve month revenue of C¥24.3b and EPS of C¥0.27 that reflects the recent move into profitability. The company has seen revenue step up from C¥7.6b in 2024 H1 to C¥9.5b in 2025 H1 and C¥10.2b in 2024 H2 on a reported basis. Basic EPS has moved from a loss of C¥0.19 in 2024 H1 and a loss of C¥0.32 in 2024 H2 to a smaller loss of C¥0.03 in the...

Yip's Chemical Holdings (SEHK:408) has reported its FY 2025 first half with revenue of HK$1,430.4 million and basic EPS of HK$0.12, set against a trailing twelve month net income of HK$137.4 million and EPS of HK$0.25, where earnings grew 41.8% over the past year. The company has seen revenue move from HK$1,557.4 million in 1H FY 2024 to HK$1,605.0 million in 2H FY 2024 and HK$1,430.4 million in 1H FY 2025, while net income excluding extra items went from HK$34.1 million to HK$62.8 million...

Hua Medicine (Shanghai) (SEHK:2552) has reported FY 2025 first half revenue of C¥217.4 million and basic EPS of C¥1.20, marking a clear break from the losses seen a year earlier when basic EPS was C¥0.15 and revenue was C¥102.7 million. Over the past three half year periods, revenue has moved from C¥102.7 million in 1H 2024 to C¥153.2 million in 2H 2024 and then to C¥217.4 million in 1H 2025. Over the same span, trailing twelve month basic EPS has shifted from a loss of C¥0.25 in 2H 2024 to a...

Liaoning Port (SEHK:2880) has posted its FY 2025 numbers with fourth quarter revenue of C¥2.9b and basic EPS of C¥0.000276, rounding out a trailing twelve month revenue base of C¥11.4b and EPS of C¥0.054807. Over recent quarters the company has seen revenue move from C¥3.1b in Q4 2024 to C¥2.9b in Q4 2025, while quarterly EPS shifted from C¥0.008271 to C¥0.000276. This sets a backdrop to the reported 14.2% earnings growth over the last year and an 11.5% trailing net margin versus 10.3% a year...

Peijia Medical (SEHK:9996) has reported FY 2025 first half results with revenue of C¥353.38 million and a basic EPS loss of C¥0.104926, alongside net income excluding extra items of a C¥69.88 million loss that keeps profitability in focus for investors. The company has seen revenue move from C¥301.20 million in 1H 2024 to C¥353.38 million in 1H 2025, while basic EPS stayed at roughly a C¥0.10 loss and trailing 12 month net income excluding extra items sits at a C¥203.29 million loss. The key...

Shanghai HeartCare Medical Technology (SEHK:6609) has just posted its FY 2025 results, with first half revenue at C¥185.5 million and basic EPS of C¥1.34, while trailing twelve month revenue sits at C¥408.3 million and EPS at C¥2.21 as the business turned profitable over the past year. The company has seen revenue move from C¥128.5 million in the first half of 2024 to C¥149.4 million in the second half of 2024 and then to C¥185.5 million in the first half of 2025. This has come alongside a...

Nissin Foods (SEHK:1475) has just wrapped up FY 2025 with fourth quarter revenue of HK$939 million and basic EPS of HK$0.07, alongside trailing twelve month revenue of HK$4.0 billion and EPS of HK$0.32 that reflect a 64.9% earnings increase over the last year. Over recent periods, revenue has ranged from HK$859 million in Q2 FY 2024 to HK$1.07 billion in Q1 FY 2025. Quarterly EPS has moved between HK$0.04 and HK$0.11, setting up a story where recent margin gains and an 8.3% net profit margin...

Excellence Commercial Property & Facilities Management Group (SEHK:6989) opened FY 2025 with first half revenue of C¥1,996.2 million and basic EPS of C¥0.12, setting the tone for another period where topline scale contrasts with tighter profitability. Over the last three reported halves, revenue has moved from C¥2,063.1 million in 1H 2024 to C¥2,149.8 million in 2H 2024 and C¥1,996.2 million in 1H 2025. Over the same period, basic EPS shifted from C¥0.14 to C¥0.12 and then C¥0.12 again,...

Mabpharm (SEHK:2181) has reported its FY 2025 first half results with revenue of C¥274.2 million and basic EPS of C¥0.000702, while trailing 12 month figures show revenue of C¥646.1 million and basic EPS of C¥0.01 as the business moves through its first year of profitability. Over the past reported periods, revenue has shifted from C¥108.5 million in 1H FY 2024 to C¥149.7 million in 2H FY 2024 and then to C¥274.2 million in 1H FY 2025, with net income moving from a loss of C¥97.6 million in...

Zhou Hei Ya International Holdings (SEHK:1458) has opened FY 2025 with first half revenue of C¥1.22b and basic EPS of C¥0.053, setting the tone against a trailing twelve month picture that shows revenue of C¥2.54b and basic EPS of about C¥0.08. Over recent periods the company has seen revenue move from C¥1.26b in 1H 2024 to C¥1.19b in 2H 2024 and C¥1.22b in 1H 2025. Over the same intervals, basic EPS shifted from C¥0.015 to C¥0.030 and then to C¥0.053, giving investors a fresh read on how...

Shougang Fushan Resources Group (SEHK:639) has released its FY 2025 first half numbers, reporting revenue of HK$2,101.4 million and basic EPS of HK$0.079, with net income of HK$404.1 million setting the tone for the period. Over the last three reported halves, revenue has moved from HK$2,531.6 million and EPS of HK$0.170 in 1H 2024 to HK$2,559.2 million and EPS of HK$0.131 in 2H 2024, before landing at the latest 1H 2025 figures. With net profit margin sitting at 12.5% versus 29.5% a year ago...

JF SmartInvest Holdings (SEHK:9636) has reported FY 2025 results with first half revenue of C¥2.1b and basic EPS of C¥1.96, backed by trailing twelve month revenue of C¥3.4b and EPS of C¥2.05 as the headline earnings numbers investors are weighing against last year. Over the past reported halves, revenue has moved from C¥898.1m in 1H 2024 to C¥1.41b in 2H 2024 and then to C¥2.1b in 1H 2025, while EPS has shifted from a loss of C¥0.40 in 1H 2024 to C¥1.03 in 2H 2024 and C¥1.96 in 1H 2025. This...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ( HKG:6990 ) just released its full-year report and things are...

Why CNOOC Shares Are Back on Investors' Radar CNOOC (SEHK:883) has caught investor attention again, with the share price moving 2.5% over the past day and showing double digit returns over the past month and past 3 months. See our latest analysis for CNOOC. That 2.5% 1 day share price gain sits within a strong upswing, with a 30 day share price return of 14.23%, a 90 day share price return of 41.84%, and a 1 year total shareholder return of 68.17%. This points to building momentum rather than...

Last week's earnings announcement from Pacific Basin Shipping Limited ( HKG:2343 ) was disappointing to investors, with...

As you might know, China Telecom Corporation Limited ( HKG:728 ) last week released its latest full-year, and things...

Investors in Green Tea Group Limited ( HKG:6831 ) had a good week, as its shares rose 4.1% to close at HK$7.90...

China Petroleum & Chemical Corporation ( HKG:386 ) missed earnings with its latest annual results, disappointing...